Tuberculose en France : nouveaux enjeux pour le praticien en 2008

D Che(Institut de Veille Sanitaire), Marie-Claire Paty(Générale de Santé), Philippe Fraisse(Société Française de Cardiologie), Nicolas Lefèbvre(Hôpital Civil, Strasbourg), D Antoine(Institut de Veille Sanitaire), Dominique Farge(Hôpital Saint-Louis), F. Antoun, M. Depinoy(Institut National de Prévention et d’Education pour la Santé)
La Revue de Médecine Interne
October 9, 2008
10.1016/j.revmed.2008.07.014
Cited by 8

Related Papers

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
|Bone Marrow Transplantation|2016|396
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
|Bone Marrow Transplantation|2015|337
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287